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Abstract – A simple and new method for the preparation of optically active
methyl 3a-chloro-, 3a-bromo-, 3a-hydroxy-, and 3a-alkoxy-1,2,3,3a,8,8a-hexa-
hydropyrrolo[2,3-b]indole-2-carboxylates has been developed.
We have been engaged in finding a simple method for the preparation of optically active methyl
1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole-2-carboxylates having an oxygen functional group at the 3a-
position as shown in general formula (1, Figure 1). Once the compounds (1) became available, creation of


















































R1-5 = an appropriate   
           substituent
a) R = α-H; b) R = β-H
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In the previous communication,1c we reported the discovery of a simple synthetic method for 3a-alkoxy-
1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indoles directly from 1-methoxy-Nb-methoxycarbonyltryptamine
by the reaction with iodine-morpholine in alcoholic solvent. Based on the results and further
examinations of reaction conditions, we have now succeeded in the first preparation of optically active,
methyl 1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole-2-carboxylates having a halogen or an oxygen
functional group at the 3a-position, which would be useful synthetic intermediates for the total synthesis
of 1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole alkaloids such as himastatin3 (2a), iso-himastatin3 (2b),
(+)-okaramine J4 (3), and so on.5
Reduction of Nb-acetyl-L-tryptophan methyl ester (4, Scheme 1) with NaBH3CN in AcOH gave Nb-
acetyl-2,3-dihydro-L-tryptophan methyl esters (5a and 6a) in 68% yield as a mixture of diasteromers in a
ratio of 1.4:1. These diastereomers (5a and 6a) were easily separated with high performance liquid
chromatography  (HPLC).  Their stereochemistries were determined as shown in Scheme 1 comparing
each 1H-NMR spectrum with the known set of diastereomers of Nb-tert-butoxycarbonyl-2,3-dihydro-L-
tryptophan methyl ester (5b and 6b) determined by Van Vranken’ group.6  
Oxidation of 5a and 6a was successfully carried out with 30% H2O2 in the presence of a catalytic amount
of Na2WO4·2H2O7 producing Nb-acetyl-1-hydroxy-L-tryptophan methyl ester ((S)-7) in 69 and 67% yields,
respectively. Similar oxidation of the mixture of diastereomers (5a and 6a) without separation gave (S)-7
in 69% yield as reported previously.8 Subsequent treatment of (S)-7 with an excess ethereal CH2N2
yielded Nb-acetyl-1-methoxy-L-tryptophan methyl ester ((S)-8) in 94% yield.8 Optical purity of (S)-8 was












































a) R = OMe
b) R = OCHMe2
c) R = Cl
d) R = Br
e) R = OH
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    6a) R = Ac
b) R = Boc
a) R = Ac
b) R = Boc
 (S)-4
a) NaBH3CN, AcOH; b) 30% H2O2, Na2WO4·2H2O, MeOH, H2O; c) CH2N2; d) I2, morpholine, in 
MeOH or i-PrOH; NCS or NBS in MeCN; e) AgCN, MeCN, H2O; f)  H2, 10% Pd/C; g) Ac2O, pyridine.
With (S)-8 in hand, various reaction conditions for converting it into optically active methyl 3a-alkoxy-
1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole-2-carboxylates (9 and 10) were thoroughly examined. As a
result, treatment of (S)-8 with iodine-morpholine in an alcoholic solvent was found to give the best results
among the examined reagent systems such as bromine, bromine-NaOAc, 4-dimethylaminopyridinium
tribromide, NIS, iodine-triethylamine, iodine-K2CO3, iodine-NaHCO3, iodine-pyridine, iodine-NaI,
iodine-NH4Cl, and iodine only. Based on these results, (S)-8 was treated with iodine (10 mol eq.) and
morpholine (3 mol eq.) in MeOH at room temperature for 2 h resulting in the formations of (2S,3aS,8aS)-
(9a) and (2S,3aR,8aR)-methyl 1-acetyl-1,2,3,3a,8,8a-hexahydro-3a,8-dimethoxypyrrolo[2,3-b]indole-2-
carboxylates (10a) in 6 and 48% yields, respectively.1e When isopropyl alcohol was employed as a
solvent, corresponding 9b and 10b were obtained in 6 and 34% yields, respectively.
On the other hand, treatment of (S)-8 with NCS (1 mol eq.) in MeCN at room temperature provided
(2S,3aS,8aS)- (9c) and (2S,3aR,8aR)-methyl 1-acetyl-3a-chloro-1,2,3,3a,8,8a-hexahydro-8-methoxy-
pyrrolo[2,3-b]indole-2-carboxylates (10c) in 42 and 42% yields, respectively. When NBS (1 mol eq.) was
employed in MeCN, (2S,3aS,8aS)- (9d) and (2S,3aR,8aR)-methyl 1-acetyl-3a-bromo-8-methoxy-
1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole-2-carboxylates (10d) were produced in 8 and 81% yields,
respectively.
We next tried to obtain optically active 3a-hydroxy compounds (9e and 10e) from 9c and 10c and found
the treatment with AgCN in MeCN-H2O was superior to AgNO3 in MeCN-H2O producing (2S,3aS,8aS)-
(9e) and (2S,3aR,8aR)-methyl 1-acetyl-3a-hydroxy-8-methoxy-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-
b]indole-2-carboxylates (10e) in 52 and 51% yields, respectively.   
The stereochemistries of 9a—e and 10a—e were deduced based on the 1H-NMR spectral data. Thus, the
methyl proton in the 2-methoxycarbonyl group of 9a—e appeared at higher magnetic field by ca.
0.20—0.24 ppm than that of 10a—e showing the methyl group is located above the benzene ring and the
protons feel the shielding effect of π-electron ring currents.
In order to obtain unequivocal proof for the above structures, the following sequence of reactions were
carried out. First, 9e was hydrogenated with 1 atm hydrogen in the presence of 10% Pd/C at room
temperature, and subsequent treatment of the product with acetic anhydride provided 78% overall yield of
(2S,3aS,8aS)-15 (Scheme 2). Similarly, 10a was hydrogenated with 1 atm hydrogen to (2S,3aR,8aR)-11 in
97% yield in the presence of 10% Pd/C at room temperature, and subsequent acetylation of (2S,3aR,8aR)-
11 with acetic anhydride provided 78% yield of (2S,3aR,8aR)-12.
On the other hand, (±)-Nb-acetyltryptophan methyl ester8 ((±)-13) was converted to (±)-methyl 3a-
acetoxy-1,8-diacetyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole-2-carboxylates ((±)-14 and (±)-15) in
21 and 23% yields, respectively, by the reaction with Ac2O at 120°C in the presence of NaOAc.
Isomerization of (±)-14 to thermodynamically stable (±)-15 occurred easily in 51% yield by the treatment
with t-BuOK in DMF, followed by acetylation with Ac2O. Subsequent hydrolysis of the 3a-acetoxy group
of (±)-14 and (±)-15 with either NaHCO3 or NaOMe in MeOH provided (±)-methyl 1,8-diacetyl-3a-
hydroxy-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole-2-carboxylates ((±)-16 and (±)-17) in 84 and 96%
yields, respectively. Luckily, (±)-17 became suitable prisms for X-Ray single crystallographic analysis.9
The results shown in Figure 2 clearly proved the structure and the presence of the methyl moiety in the 2-
methoxycarbonyl group above the benzene ring, which is responsible for the appearance of the methyl
proton at higher magnetic field by ca. 0.2 ppm than that of (±)-16 in their 1H-NMR spectra. Consequently,
stereochemistry of the 8a-proton and the 2-methoxycarbonyl group in (±)-16 and (±)-17 are proved to be
cis and trans, respectively.
The 1H-NMR spectrum and TLC behavior of (±)-15 were identical with those of optically active




























a)  H2, 10% Pd/C; b) Ac2O, pyridine; c) Ac2O, NaOAc; d) t-BuOK, DMF, 



















In conclusion, we have established simple synthetic method for optically active methyl 3a-halogeno-, 3a-
hydroxy-, and 3a-alkoxy-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole-2-carboxylates. Evaluations of
their biological activity and potential as synthetic intermediates for natural products are now in progress.
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